Given the established links between neoantigens, tumor mutational burden (TMB), and microsatellite instability (MSI) (15, 16), we observed significantly higher TMB and MSI in the MMP11-high group (Supplementary Figures S2B, C), suggesting enhanced potential for immunotherapy responsiveness. Here, MMP11 is linked to neoplasm.